How have HPV vaccines affected cervical cancer screening?

June 7, 2017
Electron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Credit: public domain

A new review looks at cervical cancer screening in the era of HPV vaccination. The review notes that trials have demonstrated the efficacy and safety of vaccines against HPV infection, but the complete effect of HPV vaccination as a cancer prevention strategy may not be fully evident for decades, given the slow progression from HPV infection to the development of cervical cancer.

Also, studies have found a positive correlation between HPV vaccination and cervical screening, in spite of a perception that vaccination would lead to patients' reassurance and decreased cervical cancer screening. Research also found no significant changes in the percentage of women reporting sexual activity or number of sexual partners between the pre- and post-vaccination era.

Vaccine cost and low provider recommendation are significant barriers for widespread HPV vaccination in the United States.

"Based on overwhelming data, it seems that the time has come for HPV testing and vaccination to take the front seat in the prevention of ," said Dr. Julieta Barroeta, lead author of the Diagnostic Cytopathology review.

Explore further: Screening, HPV vaccine can prevent cervical cancer: FDA

More information: Julieta E. Barroeta et al, Cervical cancer screening in the era of HPV vaccination: A review of shifting paradigms in cytopathology, Diagnostic Cytopathology (2017). DOI: 10.1002/dc.23737

Related Stories

HPV vaccine reduced cervical abnormalities in young women

July 4, 2016

Young women who received the human papillomavirus (HPV) vaccine through a school-based program had fewer cervical cell anomalies when screened for cervical cancer, found a new study in CMAJ (Canadian Medical Association Journal).

Recommended for you

Study sheds light on how ovarian cancer spreads

June 27, 2017

With 20,000 diagnoses each year, ovarian cancer is the ninth most common cancer and fifth leading cause of cancer death among women in the United States. So many women die from ovarian cancer because it often goes undetected ...

Cancer hijacks natural cell process to survive

June 26, 2017

Cancer tumours manipulate a natural cell process to promote their survival suggesting that controlling this mechanism could stop progress of the disease, according to new research led by the University of Oxford.

Targeted drug shows promise in rare advanced kidney cancer

June 23, 2017

Some patients with a form of advanced kidney cancer that carries a poor prognosis benefited from an experimental drug targeted to an abnormal genetic pathway causing cancerous growth, according to research led by a Dana-Farber ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.